DIVI S LABORATORIES LTD

{
    "company_profile": "Divi's Laboratories Limited is an India-based company, which is engaged in pharmaceutical ingredients (APIs), intermediates and nutraceutical ingredients with predominance in exports. The Company\u2019s products include Bupropion HCl, Capecitabine, Carbidopa, Diltiazem HCl, Dextromethorphan Base, Dextromethorphan HBr, Gabapentin, Iopamidol, Iohexol, Irbesartan, Lacosamide, Levetiracetam, Levodopa, Losartan, Nabumetone, Naproxen, Naproxen Sodium, Olmesartan Medoxomil, Pregabalin, Ticagrelor, Triprolidine HCl, Valacyclovir HCl, Valsartan, Venlafaxine HCl, Vigabatrin, and others. The Company is also engaged in custom synthesis (contract manufacturing services) of APIs and Intermediates for global innovator companies with a portfolio of products across diverse therapeutic areas. The Company\u2019s subsidiaries include Divis Laboratories (USA) Inc. and Divi\u2019s Laboratories Europe AG.",
    "sector": "Pharmaceuticals",
    "sector_market_cap_inr": {
        "value": 254318.9,
        "unit": "crore",
        "formatted": "254,318.90 Cr"
    },
    "sector_market_cap_usd": {
        "value": 28.26,
        "unit": "billion",
        "formatted": "$28.26B"
    }
}